Immunotherapy Weekly
Susan Hasty, Publisher
Table of Contents . . . November 8th, 1999
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Immunotherapy Weekly | Other Publications
Cancer Vaccines - Memory T Cells Are Recognized by CD4+ or CD8+ T Lymphocytes
Therapy (HCV) - Interleukin-10 Efficacious in Non-Responding Hepatitis C Patients
AIDS Therapies - HIV Rebounds after Stopping IL-2, Combination Antiretroviral Drug Therapy
Cancer Immunotherapy - Immune Response Enhanced by Administration of Tumor-Associated Peptides
Cancer Immunotherapy (Colon Cancer) - T-Cell Memory Is Long-Lived Even in Absence of Antigen
Colorectal Cancer (Therapy) - Immunization with an Anti-Idiotypic Monoclonal Antibody Studied
Drug Development - Novel Immunomodulatory Drug Has Antitumor Activity
Endothelial Cells - Technique Described for Endothelial Cell Seeding
Gene Mapping - Sequence and Gene Map of Human Major Histocompatibility Complex Completed
Hemophilia A - Learning How Immune System Foils Hemophilia A Treatment
Islet Transplantation - Islets Exposed to Allogenic Blood Resulted in Damage
Mesothelioma (Cancer Gene Therapy) - Immune/Antitumor Effects Realized with Transfer of IL-12
Renal Cell Carcinoma (Therapy) - Preliminary Results of Combination Therapy Are Promising
Signal Transduction (Immune Response) - Jellyfish Protein Illuminates Active Immune Cells
Vaccine Safety (Hib) - Hemophilus Meningitis Study Indicates Vaccine May Cause Diabetes
Acute Spinal Cord Injury - Spinal Cord Cell Therapy May Help Restore Body Functions
Allergy Immunotherapy - Monophosphoryl Lipid A Is Tolerable and Immunological
Cancer Gene Therapy - Genetic Manipulation Offers Hope for Numerous Disorders
Cancer Immunotherapy - Immunotherapy Uses Fusion Protein To Shrink Tumors
Cancer Vaccines - Melanoma, Ovarian Cancer Vaccine Data Presented
Melanoma (Cancer Immunotherapy) - High-Dose Interferon Therapy Well-Tolerated , But of Unknown Benefit for Melanoma
Evidence-Based Medicine - Expert Says Medical Practice Should Be Confined to Areas with Solid Scientific Basis
Industry News (Monoclonal Antibodies) - Trials of Anti-CD40 Ligand Monoclonal Antibody Halted
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
